Annual CFI
-$176.74 M
-$466.92 M-160.91%
31 December 2023
Summary:
PTC Therapeutics annual cash flow from investing activities is currently -$176.74 million, with the most recent change of -$466.92 million (-160.91%) on 31 December 2023. During the last 3 years, it has risen by +$384.81 million (+68.53%). PTCT annual CFI is now -160.91% below its all-time high of $290.18 million, reached on 31 December 2022.PTCT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$42.67 M
+$23.25 M+35.27%
30 September 2024
Summary:
PTC Therapeutics quarterly cash flow from investing activities is currently -$42.67 million, with the most recent change of +$23.25 million (+35.27%) on 30 September 2024. Over the past year, it has dropped by -$13.08 million (-44.19%). PTCT quarterly CFI is now -130.04% below its all-time high of $142.06 million, reached on 30 June 2020.PTCT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$317.95 M
-$13.08 M-4.29%
30 September 2024
Summary:
PTC Therapeutics TTM cash flow from investing activities is currently -$317.95 million, with the most recent change of -$13.08 million (-4.29%) on 30 September 2024. Over the past year, it has dropped by -$268.07 million (-537.43%). PTCT TTM CFI is now -197.53% below its all-time high of $326.02 million, reached on 30 September 2022.PTCT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -160.9% | -44.2% | -537.4% |
| 3 y3 years | +68.5% | -165.9% | -455.7% |
| 5 y5 years | -314.8% | -240.2% | -73.9% |
PTCT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -160.9% | +68.5% | -131.3% | +62.9% | -197.5% | at low |
| 5 y | 5 years | -160.9% | +68.5% | -130.0% | +89.2% | -197.5% | +45.4% |
| alltime | all time | -160.9% | +68.5% | -130.0% | +89.2% | -197.5% | +45.4% |
PTC Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$42.67 M(-35.3%) | -$317.95 M(+4.3%) |
| June 2024 | - | -$65.92 M(-42.6%) | -$304.87 M(+16.1%) |
| Mar 2024 | - | -$114.93 M(+21.7%) | -$262.70 M(+48.6%) |
| Dec 2023 | -$176.74 M(-160.9%) | -$94.42 M(+219.0%) | -$176.74 M(+254.3%) |
| Sept 2023 | - | -$29.60 M(+24.6%) | -$49.88 M(-142.9%) |
| June 2023 | - | -$23.75 M(-18.0%) | $116.16 M(-45.3%) |
| Mar 2023 | - | -$28.97 M(-189.3%) | $212.17 M(-26.9%) |
| Dec 2022 | $290.18 M(+32.4%) | $32.44 M(-76.2%) | $290.18 M(-11.0%) |
| Sept 2022 | - | $136.44 M(+88.8%) | $326.02 M(+28.2%) |
| June 2022 | - | $72.25 M(+47.3%) | $254.28 M(+6.8%) |
| Mar 2022 | - | $49.04 M(-28.2%) | $238.08 M(+8.6%) |
| Dec 2021 | $219.18 M(-139.0%) | $68.27 M(+5.5%) | $219.18 M(-483.1%) |
| Sept 2021 | - | $64.70 M(+15.4%) | -$57.21 M(-88.9%) |
| June 2021 | - | $56.06 M(+85.9%) | -$516.13 M(+20.0%) |
| Mar 2021 | - | $30.15 M(-114.5%) | -$430.13 M(-23.4%) |
| Dec 2020 | -$561.55 M(+45.0%) | -$208.12 M(-47.2%) | -$561.55 M(-3.6%) |
| Sept 2020 | - | -$394.21 M(-377.5%) | -$582.42 M(+269.1%) |
| June 2020 | - | $142.06 M(-240.3%) | -$157.78 M(-53.3%) |
| Mar 2020 | - | -$101.27 M(-55.8%) | -$338.01 M(-12.7%) |
| Dec 2019 | -$387.24 M(+808.7%) | -$229.00 M(-852.6%) | -$387.24 M(+111.8%) |
| Sept 2019 | - | $30.43 M(-179.7%) | -$182.84 M(-23.0%) |
| June 2019 | - | -$38.17 M(-74.6%) | -$237.38 M(+24.0%) |
| Mar 2019 | - | -$150.50 M(+511.9%) | -$191.46 M(+349.3%) |
| Dec 2018 | -$42.61 M | -$24.60 M(+2.0%) | -$42.61 M(-40.9%) |
| Sept 2018 | - | -$24.11 M(-411.4%) | -$72.06 M(+151.3%) |
| June 2018 | - | $7.74 M(-569.9%) | -$28.67 M(+121.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$1.65 M(-97.0%) | -$12.95 M(-198.7%) |
| Dec 2017 | $13.12 M(-87.4%) | -$54.04 M(-380.4%) | $13.12 M(-85.5%) |
| Sept 2017 | - | $19.27 M(-17.9%) | $90.29 M(-17.4%) |
| June 2017 | - | $23.47 M(-3.9%) | $109.25 M(+2.3%) |
| Mar 2017 | - | $24.42 M(+5.6%) | $106.78 M(+2.2%) |
| Dec 2016 | $104.48 M(-602.0%) | $23.13 M(-39.5%) | $104.48 M(+253.9%) |
| Sept 2016 | - | $38.24 M(+82.1%) | $29.52 M(-296.8%) |
| June 2016 | - | $21.00 M(-5.1%) | -$15.00 M(-22.3%) |
| Mar 2016 | - | $22.12 M(-142.7%) | -$19.30 M(-7.3%) |
| Dec 2015 | -$20.81 M(-85.7%) | -$51.83 M(+724.8%) | -$20.81 M(-74.7%) |
| Sept 2015 | - | -$6.28 M(-137.6%) | -$82.17 M(+198.7%) |
| June 2015 | - | $16.70 M(-19.0%) | -$27.50 M(-77.1%) |
| Mar 2015 | - | $20.61 M(-118.2%) | -$120.29 M(-17.1%) |
| Dec 2014 | -$145.17 M(+13.6%) | -$113.19 M(-334.0%) | -$145.17 M(+455.9%) |
| Sept 2014 | - | $48.38 M(-163.6%) | -$26.11 M(-86.7%) |
| June 2014 | - | -$76.09 M(+1683.3%) | -$196.51 M(+48.8%) |
| Mar 2014 | - | -$4.27 M(-172.7%) | -$132.07 M(+3.3%) |
| Dec 2013 | -$127.83 M(>+9900.0%) | $5.87 M(-104.8%) | -$127.83 M(-4.4%) |
| Sept 2013 | - | -$122.02 M(+946.5%) | -$133.70 M(+1043.8%) |
| June 2013 | - | -$11.66 M(>+9900.0%) | -$11.69 M(>+9900.0%) |
| Mar 2013 | - | -$21.00 K(+281.8%) | -$51.60 K(-72.7%) |
| Dec 2012 | -$189.00 K(-100.7%) | -$5500.00(+27.9%) | -$189.00 K(+3.0%) |
| Sept 2012 | - | -$4300.00(-79.3%) | -$183.50 K(+2.4%) |
| June 2012 | - | -$20.80 K(-86.9%) | -$179.20 K(+13.1%) |
| Mar 2012 | - | -$158.40 K | -$158.40 K |
| Dec 2011 | $27.70 M | - | - |
FAQ
- What is PTC Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for PTC Therapeutics?
- What is PTC Therapeutics annual CFI year-on-year change?
- What is PTC Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PTC Therapeutics?
- What is PTC Therapeutics quarterly CFI year-on-year change?
- What is PTC Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for PTC Therapeutics?
- What is PTC Therapeutics TTM CFI year-on-year change?
What is PTC Therapeutics annual cash flow from investing activities?
The current annual CFI of PTCT is -$176.74 M
What is the all time high annual CFI for PTC Therapeutics?
PTC Therapeutics all-time high annual cash flow from investing activities is $290.18 M
What is PTC Therapeutics annual CFI year-on-year change?
Over the past year, PTCT annual cash flow from investing activities has changed by -$466.92 M (-160.91%)
What is PTC Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PTCT is -$42.67 M
What is the all time high quarterly CFI for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash flow from investing activities is $142.06 M
What is PTC Therapeutics quarterly CFI year-on-year change?
Over the past year, PTCT quarterly cash flow from investing activities has changed by -$13.08 M (-44.19%)
What is PTC Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PTCT is -$317.95 M
What is the all time high TTM CFI for PTC Therapeutics?
PTC Therapeutics all-time high TTM cash flow from investing activities is $326.02 M
What is PTC Therapeutics TTM CFI year-on-year change?
Over the past year, PTCT TTM cash flow from investing activities has changed by -$268.07 M (-537.43%)